Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53222

language	eng
Author	Tamaki, Yukihisa Hieda, Yoko Nakajima Masanobu Department of Surgery I, Dokkyo Medical University Kitajima Kazuhiro Department of Radiology, Division of Nuclear Medicine and PET Center, Hyogo College of Medicine Yoshida, Rika Yoshizako, Takeshi UE, Atsushi Tokudo Mutsumi Department of Radiation Oncology, Shimane University Faculty of Medicine Hirahara, Noriyuki MORIYAMA, Ichiro Kato Hiroyuki Department of Surgery I, Dokkyo Medical University Inomata Taisuke Department of Radiation Oncology, Shimane University Faculty of Medicine
Subject	esophageal cancer; concurrent chemoradiotherapy; docetaxel; cisplatin; 5-fluorouracil; overall survival
Journal Title	JOURNAL OF CANCER
Volume	9
Issue	16
Start Page	2765
End Page	2772
ISSN	1837-9664
Published Date	2018
DOI	10.7150/jca.23456
PubMed ID	30123343
Publisher	IVYSPRING INT PUBL
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	The authors acknowledge the support of the Department of Radiotherapy, Gastrointestinal Surgery and Gastroenterology at Shimane University Hospital and Dokkyo Medical University Hospital.